The FDA has even accredited a drug made with cannabidiol for that intent (Epidiolex). Even so the agency only suggests it for 2 unusual varieties of childhood epilepsy known as Lennox-Gastaut syndrome and Dravet syndrome. Provided these related genetic and environmental vulnerabilities, more details from future, longitudinal investigation (studies that https://marioralfl.blogsuperapp.com/35581651/the-fact-about-psychoactive-cannabinoids-that-no-one-is-suggesting